{
    "Additional Indicators": [
        {
            "description": "Unfavorable Prognosis",
            "therapy": "NCCN, Consensus, Non-Small Cell Lung Cancer",
            "mutation": "KRASp.G12C Gain-of-function"
        }
    ],
    "Clinical trials": [
        {
            "description": "A Study of VS-6766 v. VS-6766 + Defactinib in Recurrent G12V, Other KRAS and BRAF Non-Small Cell Lung Cancer ",
            "phase": "Phase 2",
            "mutations": [
                "KRAS"
            ]
        },
        {
            "description": "A Phase 1/2 Study of MRTX849 in Patients With Cancer Having a KRAS G12C Mutation KRYSTAL-1",
            "phase": "Phase 1/2",
            "mutations": [
                "KRAS",
                "STK11"
            ]
        },
        {
            "description": "First-in-human Study of DRP-104 (Sirpiglenastat) as Single Agent and in Combination With Atezolizumab in Patients With Advanced Solid Tumors. (NCT04471415)",
            "phase": "Phase 1/2",
            "mutations": [
                "NFE2L2",
                "STK11"
            ]
        }
    ],
    "variants of unknown significance": {
        "Somatic": [
            {
                "Gene": "ALDH2",
                "DNA Alteration": "c.1510G>A",
                "GeneMutation": "p.E504K Nonsense-LOF",
                "VariantAlleleFraction": "24.57%"
            },
            {
                "Gene": "RNF43",
                "DNA Alteration": "c.505G>A",
                "GeneMutation": "p.E318D Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "15.53%"
            },
            {
                "Gene": "MYO1G",
                "DNA Alteration": "c.145G>A",
                "GeneMutation": "p.V49M Stopgain-LOF",
                "VariantAlleleFraction": "2.42%"
            },
            {
                "Gene": "CSF3R",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.G751A Spliceregionvariant-GOF",
                "VariantAlleleFraction": "4.39%"
            },
            {
                "Gene": "FGFR2",
                "DNA Alteration": "c.755C>G",
                "GeneMutation": "p.C382R Nonsense-LOF",
                "VariantAlleleFraction": "5.58%"
            },
            {
                "Gene": "EGFR",
                "DNA Alteration": "c.2239_2256del18",
                "GeneMutation": "p.L747_P753del Frameshift-LOF",
                "VariantAlleleFraction": "2.96%"
            },
            {
                "Gene": "ALDH2",
                "DNA Alteration": "c.1510G>A",
                "GeneMutation": "p.E504K Frameshift-LOF",
                "VariantAlleleFraction": "7.78%"
            },
            {
                "Gene": "CDC73",
                "DNA Alteration": "c.1A>G",
                "GeneMutation": "p.M1V Spliceregionvariant-GOF",
                "VariantAlleleFraction": "5.71%"
            },
            {
                "Gene": "IDH2",
                "DNA Alteration": "c.419G>A",
                "GeneMutation": "p.R172K Nonsense-LOF",
                "VariantAlleleFraction": "7.38%"
            }
        ],
        "Germline": []
    }
}